Loading...
XNYSCNMD
Market cap2.14bUSD
Dec 23, Last price  
69.18USD
1D
0.80%
1Q
-9.27%
Jan 2017
56.62%
Name

Conmed Corp

Chart & Performance

D1W1MN
XNYS:CNMD chart
P/E
33.15
P/S
1.72
EPS
2.09
Div Yield, %
1.15%
Shrs. gr., 5y
1.78%
Rev. gr., 5y
7.68%
Revenues
1.24b
+19.06%
558,388,000617,305,000646,812,000694,288,000742,183,000694,739,000713,723,000725,077,000767,140,000756,755,000734,467,000719,168,000763,520,000796,392,000859,634,000955,097,000862,459,0001,010,635,0001,045,472,0001,244,744,000
Net income
64m
P
33,465,00031,994,000-12,507,00041,456,00044,561,00012,137,00030,346,000752,00040,481,00035,939,00032,192,00030,498,00014,664,00055,487,00040,854,00028,620,0009,517,00062,542,000-80,582,00064,459,000
CFO
125m
+275.69%
74,840,00042,434,00064,572,00065,894,00061,149,00025,028,00038,243,000102,993,00095,199,00080,949,00065,176,00048,068,00038,222,00065,566,00074,701,00095,133,00064,531,000111,770,00033,365,000125,348,000
Dividend
Sep 16, 20240.2 USD/sh
Earnings
Jan 29, 2025

Profile

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
URL
https://www.conmed.com/
IPO date
Jul 23, 1987
Employees
4,100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,244,744
19.06%
1,045,472
3.45%
1,010,635
17.18%
Cost of revenue
621,101
521,379
486,164
Unusual Expense (Income)
NOPBT
623,643
524,093
524,471
NOPBT Margin
50.10%
50.13%
51.90%
Operating Taxes
16,369
9,720
10,563
Tax Rate
2.62%
1.85%
2.01%
NOPAT
607,274
514,373
513,908
Net income
64,459
-179.99%
(80,582)
-228.84%
62,542
557.16%
Dividends
(24,502)
(23,960)
(23,256)
Dividend yield
0.71%
0.90%
0.51%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
8,217
69,746
12,249
Long-term debt
994,591
996,887
672,647
Deferred revenue
66,725
Other long-term liabilities
111,131
136,969
42,992
Net debt
978,512
1,037,691
664,049
Cash flow
Cash from operating activities
125,348
33,365
111,770
CAPEX
(19,032)
(21,785)
(14,866)
Cash from investing activities
(20,032)
(249,529)
(14,866)
Cash from financing activities
(110,432)
225,000
(101,548)
FCF
638,800
437,026
486,554
Balance
Cash
24,296
28,942
20,847
Long term investments
Excess cash
Stockholders' equity
402,674
355,086
442,715
Invested Capital
1,936,607
2,004,061
1,513,083
ROIC
30.82%
29.25%
33.78%
ROCE
31.22%
25.31%
33.16%
EV
Common stock shares outstanding
31,548
30,040
32,216
Price
109.51
23.54%
88.64
-37.47%
141.76
26.57%
Market cap
3,454,821
29.75%
2,662,746
-41.70%
4,566,940
38.39%
EV
4,433,333
3,700,437
5,230,989
EBITDA
675,043
593,612
595,214
EV/EBITDA
6.57
6.23
8.79
Interest
39,775
28,905
35,485
Interest/NOPBT
6.38%
5.52%
6.77%